@FiercePharma: Bayer's new cancer drug Stivarga (with Onyx) wins approval in Europe, for metastatic colorectal. Release | Follow @FiercePharma
@EricPFierce: J&J takes another step to warn consumers that if you take too much acetaminophen, it will kill you. Story | Follow @EricPFierce
@CarlyHFierce: Cubist recalls four lots of antibiotic Cubicin because of glass particles. More from FiercePharmaManufacturing | Follow @CarlyHFierce
> Sanofi's ($SNY) Genzyme said the European Commission has approved Aubagio, its once-daily pill for treating adults with relapsing remitting multiple sclerosis. Release
> The National Institute for Health and Care Excellence (NICE) has recommended Novartis' ($NVS) Jetrea in the U.K. for treatment of a rare eye condition called vitreomacular traction. Story
> A study found that therapeutic drug substitutions, using less expensive substitutes that are not equivalent but have a similar treatment effect as the original medication, could save payers about three times more than generics. Story
> An FDA official in India says the agency is not specifically targeting Indian companies for enforcement. Story
@FierceMedDev: Meda grabs MA maker of asthma inhaler for $135M. Story | Follow @FierceMedDev
@MarkHFierce: Covidien won yet another patent battle with a rival. Patent spats aren't cheap. News | Follow @MarkHFierce
@MichaelGFierce: European public health group gets behind tighter device controls. Item | Follow @MichaelGFierce
> Texas neurostim startup pulls in $3.4M for multiple trials. Article
> Medtronic looks to innovate with new Singapore shop. More
> Covidien claims victory in surgical tool patent dustup. Story
Biotech News
@FierceBiotech: Report: Big CROs soared 10% last year. More from FierceCRO | Follow @FierceBiotech
@RyanMFierce: Icon Bioscience snags $15M in B round for eye therapies. News | Follow @RyanMFierce
@EmilyMFierce: ICYMI: UM Pharmacy School researchers develop new opioid pain drug that decreases tolerance, side effects. Article | Follow @EmilyMFierce
> Report: Clarus, OrbiMed pioneer paths to biotech VC victories. Story
> Meda to scoop up Sequoia-backed pharma startup Acton for $135M. Report
> Johnson & Johnson inks R&D pact to fight growing threat of dengue infections. More
And Finally... A design award has gone to Kanupriya Goel and biologist Gautam Goel for a drug label that reacts over time to reveal a hidden message that the drug is expired. Story